Tiziana Life Sciences Ltd (TLSA)
NASDAQ: TLSA · Real-Time Price · USD
1.240
-0.010 (-0.80%)
At close: Mar 27, 2026, 4:00 PM EDT
1.260
+0.020 (1.61%)
After-hours: Mar 27, 2026, 6:33 PM EDT
Tiziana Life Sciences Employees
Tiziana Life Sciences had 9 employees as of December 31, 2024. The number of employees did not change compared to the previous year.
Employees
9
Change (1Y)
n/a
Growth (1Y)
n/a
Revenue / Employee
n/a
Profits / Employee
-$1,426,778
Market Cap
158.25M
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2024 | 9 | 0 | - |
| Dec 31, 2023 | 9 | 0 | - |
| Dec 31, 2022 | 9 | -5 | -35.71% |
| Dec 31, 2021 | 14 | 3 | 27.27% |
| Dec 31, 2020 | 11 | 3 | 37.50% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Jasper Therapeutics | 27 |
| Actinium Pharmaceuticals | 25 |
| PDS Biotechnology | 24 |
| INmune Bio | 22 |
| ABVC BioPharma | 19 |
| BriaCell Therapeutics | 16 |
| Hyperion DeFi | 14 |
| Serina Therapeutics | 13 |
TLSA News
- 4 weeks ago - Tiziana Life Sciences Announces New Biomarker Data Showing Nasal Foralumab Downregulates CSF Inflammation, Upregulates Neuroprotective Pathways, and Correlates with Reduced Microglial Activation on PET Scans in na-SPMS Patients with PIRA - GlobeNewsWire
- 2 months ago - Tiziana Life Sciences Announces the Peer-Reviewed Publication of Clinical Study Results for Intranasal Foralumab - GlobeNewsWire
- 2 months ago - Tiziana Life Sciences Announces Closing of Oversubscribed $8.8 Million Registered Direct Offering of Ordinary Shares - GlobeNewsWire
- 2 months ago - Tiziana Life Sciences Announces Registered Direct Offering of up to approximately $17.6 Million - GlobeNewsWire
- 2 months ago - Tiziana Life Sciences to Present at the 9th Annual Neuroscience Innovation Forum During J.P. Morgan Healthcare Conference Week in San Francisco - GlobeNewsWire
- 3 months ago - Tiziana Files Annual Safety Report for Intranasal Foralumab with FDA - GlobeNewsWire
- 3 months ago - Tiziana Life Sciences Announces Acquisition of Shares by Executive Chairman - GlobeNewsWire
- 3 months ago - Tiziana Life Sciences to Ring the Closing Bell at Nasdaq - GlobeNewsWire